DEPRESSION PATENT FOR OROTATE APPROVED & GRANTED BY US PATENT OFFICE
11 oct. 2021 10h40 HE
|
Medlab Clinical Ltd
SYDNEY, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Medlab Clinical LTD (ASX:MDC) is pleased to announce the Orotate patent, specifically to addressing depression in United States of America has been granted....
NANOCELLE “ISSUE OF ALLOWANCE” BY US PATENT OFFICE
06 oct. 2021 11h10 HE
|
Medlab Clinical Ltd
SYDNEY, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Medlab Clinical LTD (ASX.MDC) is pleased to announce NanoCelle® the company’s proprietary delivery platform has been issued a “Notice of Allowance” by the...
US Patent Office issues Notice of Allowance status for NRGBiotic™ for treating, preventing, or Ameliorating depression or a Depressive disorder.
27 juil. 2021 09h06 HE
|
Medlab Clinical Ltd
SYDNEY, July 27, 2021 (GLOBE NEWSWIRE) -- Medlab Clinical Ltd (ASX.MDC), an Australian biotech using delivery platforms to enhance medicines is very pleased to announce the United States Patent...